The effect analysis on the temporary stent-grafttreatmentof esophageal achulasia disease

Abstract

Objective To analyse and explore the adverse factors and solutions on the temporary stent-graft treatment of esophageal achalasia disease. Methods 39 patients with diagnosis of esophageal achalasia disease of were studied. There were male group(21 cases)and female group(18 cases) ,ranging from 15 to 64-years-old. The longest disease course was 27 years and the shortest was only 1 year. They have been treated 43 times. All cases have been esophagealled by barium med examination(narrow less than 5 mm)and Endoscopic biopsy(benign) confirmed. To select China-made recyclable plastic self-expanding stent, to adopt one-step into the esophagus, Stent stay for 2 weeks or 3 weeks. Symptomatic treatment after operation, oral 0.9% NS. 250 ml gentamicin plus 80,000 units,3 times/day and 3 consecutive days. Results All cases of stent placement was successful only once. During the treatment,2 cases stent slided into stomach in 10 days, 1 case of them remove the stent and then placement again, and another case didn't replace. In addition, one case removed the stent in 12th days. To remove the stent and then review esophageal barium med examination ,which have been confirmed the esophagus were expandment in vary degrees. After six months, 8 cases of recurrence, two of which adopted routine surgical treatment ,4 cases of re-line treatment of esophageal stent. The remaining patients effect were sta-ble,reached a maximum of 79 months not to treat again. In the process of implementation during the operation, there have not severe complications such as esophageal rupture ,bleeding. Conclusion To analyse the 39 cases transesophageal treatment of patients with stents, we can seen the esophageal stents in the treatment of esophage-al achalasia disease is safe and effective. Through controlling the eating habits of patients, choosing to the pa-tients and the adjustment to the esophageal stent sizes, we can concluded the treatment can improve the efficien-cy and then reduce recurrence of the disease. Key words: Temporary; Membranous stent; Esophageal achalasia disease; Analysis of efficiecy